ArticleLACTATE (cas 113-21-3) Is a Natural Suppressor of RLR Signaling by Targeting MAVS

Add time:08/26/2019    Source:sciencedirect.com

SummaryRLR-mediated type I IFN production plays a pivotal role in elevating host immunity for viral clearance and cancer immune surveillance. Here, we report that glycolysis, which is inactivated during RLR activation, serves as a barrier to impede type I IFN production upon RLR activation. RLR-triggered MAVS-RIG-I recognition hijacks hexokinase binding to MAVS, leading to the impairment of hexokinase mitochondria localization and activation. Lactate serves as a key metabolite responsible for glycolysis-mediated RLR signaling inhibition by directly binding to MAVS transmembrane (TM) domain and preventing MAVS aggregation. Notably, lactate restoration reverses increased IFN production caused by lactate deficiency. Using pharmacological and genetic approaches, we show that lactate reduction by lactate dehydrogenase A (LDHA) inactivation heightens type I IFN production to protect mice from viral infection. Our study establishes a critical role of glycolysis-derived lactate in limiting RLR signaling and identifies MAVS as a direct sensor of lactate, which functions to connect energy metabolism and innate immunity.

We also recommend Trading Suppliers and Manufacturers of LACTATE (cas 113-21-3). Pls Click Website Link as below: cas 113-21-3 suppliers

Prev:An ultrasensitive amperometric determination of LACTATE (cas 113-21-3) by LACTATE (cas 113-21-3) dehydrogenase nanoparticles immobilized onto Au electrode
Next:The NIR inspired nano-CuSMn(II) composites for LACTATE (cas 113-21-3) and glycolysis attenuation)